DR REDDYS LABORATORIES
Back to All Ratios
|
DR REDDYS LABORATORIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 74.45 | 89.08 | 84.51 | 69.12 | 40.24 |
What is the latest Cash Earnings per Share (CEPS) ratio of DR REDDYS LABORATORIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2026 | 74.45 |
| Mar2025 | 89.08 |
| Mar2024 | 84.51 |
| Mar2023 | 69.12 |
| Mar2022 | 40.24 |
How is Cash Earnings per Share (CEPS) of DR REDDYS LABORATORIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2026 | 74.45 | -16.42 | |
| Mar2025 | 89.08 | 5.41 | |
| Mar2024 | 84.51 | 22.27 | |
| Mar2023 | 69.12 | 71.77 | |
| Mar2022 | 40.24 | - | |
Other Financial Ratios of DR REDDYS LABORATORIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹115,020.8 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
| MANKIND PHARMA | ₹109,622.0 Cr | 3% | 13.9% | 17.8% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.6% |
13.4% |
15.7% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses